{
    "version": "https://jsonfeed.org/version/1.1",
    "title": "Harvard Health Posts by C.W. Schmidt Feed",
    "home_page_url": "https://www.health.harvard.edu/authors/charlie-schmidt",
    "feed_url": "https://www.health.harvard.edu/authors/charlie-schmidt/feed/json",
    "language": "en-US",
    "icon": "https://www.health.harvard.edu/img/logos/hhp-logo-mark-lg.jpg",
    "items": [{
            "id": "https://www.health.harvard.edu/blog/can-men-hold-off-on-treating-recurring-prostate-cancer-202512193108",
            "title": "Can men hold off on treating recurring prostate cancer?",
            "url": "https://www.health.harvard.edu/blog/can-men-hold-off-on-treating-recurring-prostate-cancer-202512193108",
            "content_html": "What happens if PSA levels start rising after surgery or radiation for prostate cancer? Sometimes men live the rest of their lives with a rising PSA without ever developing metastases. Now, an ultra-sensitive scanning technology is raising new questions about biochemical recurrence and how to manage it.",
            "summary": "What happens if PSA levels start rising after surgery or radiation for prostate cancer? Sometimes men live the rest of their lives with a rising PSA without ever developing metastases. Now, an ultra-sensitive scanning technology is raising new questions about biochemical recurrence and how to manage it.",
            "date_published": "2025-12-19T10:30:00-05:00",
            "date_modified": "2025-12-19T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/17403/conversions/gettyimages-2208364037-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Medications and treatments" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/how-does-prostate-cancer-treatment-affect-mental-health-202511213107",
            "title": "How does prostate cancer treatment affect mental health?",
            "url": "https://www.health.harvard.edu/blog/how-does-prostate-cancer-treatment-affect-mental-health-202511213107",
            "content_html": "The long-term outlook for men diagnosed with prostate cancer continues to improve. These medical advances, however, have also drawn attention to the mental health challenges many survivors encounter. It's still common for survivors to struggle with loss of masculine self-esteem and changes in body image.",
            "summary": "The long-term outlook for men diagnosed with prostate cancer continues to improve. These medical advances, however, have also drawn attention to the mental health challenges many survivors encounter. It's still common for survivors to struggle with loss of masculine self-esteem and changes in body image.",
            "date_published": "2025-11-21T10:30:00-05:00",
            "date_modified": "2025-11-21T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/17306/conversions/gettyimages-1048189202-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Mental Health","Medications and treatments" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/what-are-the-symptoms-of-prostate-cancer-202509173105",
            "title": "Symptoms of early-stage prostate cancer",
            "url": "https://www.health.harvard.edu/blog/what-are-the-symptoms-of-prostate-cancer-202509173105",
            "content_html": "Prostate cancer often develops quietly, with few or no early warning signs, and can resemble normal age‑related prostate changes. When symptoms arise, they usually involve subtle changes in urination. Doctors combine careful questioning, physical examination, blood tests, and modern scans to distinguish harmless enlargement from serious disease.",
            "summary": "Prostate cancer often develops quietly, with few or no early warning signs, and can resemble normal age‑related prostate changes. When symptoms arise, they usually involve subtle changes in urination. Doctors combine careful questioning, physical examination, blood tests, and modern scans to distinguish harmless enlargement from serious disease.",
            "date_published": "2025-09-17T10:30:00-04:00",
            "date_modified": "2025-09-17T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/17061/conversions/gettyimages-1376569576-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medical Tests & Procedures" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/how-is-psa-used-to-monitor-prostate-cancer-202507283103",
            "title": "How is PSA used to monitor prostate cancer?",
            "url": "https://www.health.harvard.edu/blog/how-is-psa-used-to-monitor-prostate-cancer-202507283103",
            "content_html": "Men on active surveillance for low-risk prostate cancer might need treatment if their PSA levels start to rise. Doctors also measure PSA to check for recurring cancer in men who were already treated with surgery or radiation. But use of the test in such cases differs in important ways.",
            "summary": "Men on active surveillance for low-risk prostate cancer might need treatment if their PSA levels start to rise. Doctors also measure PSA to check for recurring cancer in men who were already treated with surgery or radiation. But use of the test in such cases differs in important ways.",
            "date_published": "2025-07-28T10:30:00-04:00",
            "date_modified": "2025-07-28T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/16925/conversions/gettyimages-2208364037-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/what-is-a-psa-test-and-how-is-it-used-202507143101",
            "title": "What is a PSA test and how is it used?",
            "url": "https://www.health.harvard.edu/blog/what-is-a-psa-test-and-how-is-it-used-202507143101",
            "content_html": "Every year, millions of men around the world get a prostate-specific antigen (PSA) test. Abnormal readings on the test suggest a man might have prostate cancer. But how should an abnormal result be interpreted?",
            "summary": "Every year, millions of men around the world get a prostate-specific antigen (PSA) test. Abnormal readings on the test suggest a man might have prostate cancer. But how should an abnormal result be interpreted?",
            "date_published": "2025-07-14T10:30:00-04:00",
            "date_modified": "2025-07-14T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/16840/conversions/gettyimages-1432980561-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/how-is-metastatic-prostate-cancer-detected-and-treated-in-men-over-70-202505273099",
            "title": "How is metastatic prostate cancer detected and treated in men over 70?",
            "url": "https://www.health.harvard.edu/blog/how-is-metastatic-prostate-cancer-detected-and-treated-in-men-over-70-202505273099",
            "content_html": "The US Preventive Services Task Force recommends against screening for prostate cancer in men older than 70, but as life expectancy for this group increases and treatment options evolve, it's important for men to be aware of their options.",
            "summary": "The US Preventive Services Task Force recommends against screening for prostate cancer in men older than 70, but as life expectancy for this group increases and treatment options evolve, it's important for men to be aware of their options.",
            "date_published": "2025-05-27T11:30:00-04:00",
            "date_modified": "2025-05-27T11:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/16720/conversions/gettyimages-1299109777-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Medications and treatments" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/can-saw-palmetto-treat-an-enlarged-prostate-Z8MFO89Q-202504163094",
            "title": "Can saw palmetto treat an enlarged prostate?",
            "url": "https://www.health.harvard.edu/blog/can-saw-palmetto-treat-an-enlarged-prostate-Z8MFO89Q-202504163094",
            "content_html": "Marketed as a natural remedy for an enlarged prostate, saw palmetto is a top-selling dietary supplement. By one estimate, more than a third of all US adults who take supplements use saw palmetto. But experts at Harvard say men should view its supposed benefits for prostate health skeptically.",
            "summary": "Marketed as a natural remedy for an enlarged prostate, saw palmetto is a top-selling dietary supplement. By one estimate, more than a third of all US adults who take supplements use saw palmetto. But experts at Harvard say men should view its supposed benefits for prostate health skeptically.",
            "date_published": "2025-04-16T10:30:00-04:00",
            "date_modified": "2025-04-16T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/16547/conversions/gettyimages-899993536-thumb.jpg",

            "tags": [ "Men's Health","Men's Health","Vitamins, minerals, herbs, and supplements","Prostate Cancer" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/what-is-prostatitis-and-how-is-it-treated-202503253092",
            "title": "What is prostatitis and how is it treated?",
            "url": "https://www.health.harvard.edu/blog/what-is-prostatitis-and-how-is-it-treated-202503253092",
            "content_html": "The troubling symptoms of prostatitis, or inflammation of the prostate, accounts for roughly two million doctor visits every year. Fortunately, research advances are leading to some encouraging developments for men suffering from this condition.",
            "summary": "The troubling symptoms of prostatitis, or inflammation of the prostate, accounts for roughly two million doctor visits every year. Fortunately, research advances are leading to some encouraging developments for men suffering from this condition.",
            "date_published": "2025-03-25T10:30:00-04:00",
            "date_modified": "2025-03-25T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/16501/conversions/gettyimages-947316424-thumb.jpg",

            "tags": [ "Men's Health","Men's Health","Medications and treatments","Sexual Health","Prostate Cancer" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/supporting-a-loved-one-with-prostate-cancer-a-guide-for-caregivers-202502263089",
            "title": "Supporting a loved one with prostate cancer: A guide for caregivers",
            "url": "https://www.health.harvard.edu/blog/supporting-a-loved-one-with-prostate-cancer-a-guide-for-caregivers-202502263089",
            "content_html": "Looking after a loved one who has prostate cancer can be overwhelming. Caregivers play crucial roles in supporting a patient's physical and psychological well-being. But what does that entail? Here's what to know about effective communication, day-to-day support, and taking care of yourself.",
            "summary": "Looking after a loved one who has prostate cancer can be overwhelming. Caregivers play crucial roles in supporting a patient's physical and psychological well-being. But what does that entail? Here's what to know about effective communication, day-to-day support, and taking care of yourself.",
            "date_published": "2025-02-26T10:30:00-05:00",
            "date_modified": "2025-02-26T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/16400/conversions/gettyimages-2191870177-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Caregiving","Mental Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/new-surgery-for-benign-prostate-hyperplasia-provides-long-lasting-benefits-202501233087",
            "title": "New surgery for benign prostate hyperplasia provides long-lasting benefits",
            "url": "https://www.health.harvard.edu/blog/new-surgery-for-benign-prostate-hyperplasia-provides-long-lasting-benefits-202501233087",
            "content_html": "Most men over 50 will develop an enlarged prostate. Many different therapies are available, including medications and various types of surgery. Aquablation is gaining in popularity, and a recent study showed that improvements in urinary function from aquablation were still holding up after five years.",
            "summary": "Most men over 50 will develop an enlarged prostate. Many different therapies are available, including medications and various types of surgery. Aquablation is gaining in popularity, and a recent study showed that improvements in urinary function from aquablation were still holding up after five years.",
            "date_published": "2025-01-23T10:30:00-05:00",
            "date_modified": "2025-01-23T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/16140/conversions/gettyimages-1334946772-thumb.jpg",

            "tags": [ "Men's Health","Men's Health","Medications and treatments","Prostate Cancer" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/lets-not-call-it-cancer-202501093086",
            "title": "Let's not call it cancer",
            "url": "https://www.health.harvard.edu/blog/lets-not-call-it-cancer-202501093086",
            "content_html": "Roughly one in six men will be diagnosed with prostate cancer at some point in their lives, but these cancers usually aren't life-threatening. The least risky form of the disease occurs frequently with age, will not metastasize to other parts of the body, and it doesn't require any immediate treatment. So, should it even be called cancer?",
            "summary": "Roughly one in six men will be diagnosed with prostate cancer at some point in their lives, but these cancers usually aren't life-threatening. The least risky form of the disease occurs frequently with age, will not metastasize to other parts of the body, and it doesn't require any immediate treatment. So, should it even be called cancer?",
            "date_published": "2025-01-09T10:30:00-05:00",
            "date_modified": "2025-01-09T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/16067/conversions/gettyimages-1178748795-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medical Tests & Procedures" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/a-liquid-biopsy-for-metastatic-prostate-cancer-202501033085",
            "title": "A liquid biopsy for metastatic prostate cancer",
            "url": "https://www.health.harvard.edu/blog/a-liquid-biopsy-for-metastatic-prostate-cancer-202501033085",
            "content_html": "Researchers are developing tools for predicting how fast prostate cancer might progress; among the most promising are those that count circulating tumor cells (CTCs) in blood samples. Research shows that high CTC counts predict poorer survival and faster disease progression. But they are also predictive for early-stage metastatic prostate cancer that still responds to hormonal therapy.",
            "summary": "Researchers are developing tools for predicting how fast prostate cancer might progress; among the most promising are those that count circulating tumor cells (CTCs) in blood samples. Research shows that high CTC counts predict poorer survival and faster disease progression. But they are also predictive for early-stage metastatic prostate cancer that still responds to hormonal therapy.",
            "date_published": "2025-01-03T06:30:00-05:00",
            "date_modified": "2025-01-03T06:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/16054/conversions/gettyimages-1299109777-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medical Tests & Procedures" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/prostate-cancer-short-course-radiation-as-effective-as-longer-term-treatments-202412103084",
            "title": "Prostate cancer: Short-course radiation as effective as longer-term treatments",
            "url": "https://www.health.harvard.edu/blog/prostate-cancer-short-course-radiation-as-effective-as-longer-term-treatments-202412103084",
            "content_html": "Radiation therapy for prostate cancer used to involve weeks or months of treatment. Today, radiation delivery is moving toward higher doses given with fewer sessions over shorter durations. Results from a clinical trial show that the two types of therapy offer the same long-term benefits.",
            "summary": "Radiation therapy for prostate cancer used to involve weeks or months of treatment. Today, radiation delivery is moving toward higher doses given with fewer sessions over shorter durations. Results from a clinical trial show that the two types of therapy offer the same long-term benefits.",
            "date_published": "2024-12-10T10:30:00-05:00",
            "date_modified": "2024-12-10T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/15976/conversions/gettyimages-2157683173-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medications and treatments" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/could-imaging-scans-replace-biopsies-during-prostate-cancer-screening-202411083080",
            "title": "Could imaging scans replace biopsies during prostate cancer screening?",
            "url": "https://www.health.harvard.edu/blog/could-imaging-scans-replace-biopsies-during-prostate-cancer-screening-202411083080",
            "content_html": "Abnormal results on a prostate-specific antigen (PSA) screening test for cancer are typically followed by a systematic biopsy. But systematic biopsies can be problematic, and researchers are seeking alternatives. A large European study provides encouraging evidence favoring a different approach that uses MRI instead of biopsy.",
            "summary": "Abnormal results on a prostate-specific antigen (PSA) screening test for cancer are typically followed by a systematic biopsy. But systematic biopsies can be problematic, and researchers are seeking alternatives. A large European study provides encouraging evidence favoring a different approach that uses MRI instead of biopsy.",
            "date_published": "2024-11-08T06:30:00-05:00",
            "date_modified": "2024-11-08T06:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/15843/conversions/gettyimages-170089177-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medical Tests & Procedures" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/car-t-immunotherapy-for-prostate-cancer-202409163070",
            "title": "CAR-T immunotherapy for prostate cancer?",
            "url": "https://www.health.harvard.edu/blog/car-t-immunotherapy-for-prostate-cancer-202409163070",
            "content_html": "The specialized cells of our immune systems help to keep us healthy and free of infectious diseases. Immunotherapies teach those same cells to recognize and destroy cancer. Researchers are reporting promising results with a different method that involves engineered cells studded with receptors that bind to specific targets on cancer cells.",
            "summary": "The specialized cells of our immune systems help to keep us healthy and free of infectious diseases. Immunotherapies teach those same cells to recognize and destroy cancer. Researchers are reporting promising results with a different method that involves engineered cells studded with receptors that bind to specific targets on cancer cells.",
            "date_published": "2024-09-16T10:30:00-04:00",
            "date_modified": "2024-09-16T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/15620/conversions/gettyimages-1766446189-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medications and treatments" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/testosterone-blocking-drugs-boost-heart-disease-risk-when-given-in-combination-202407263061",
            "title": "Testosterone-blocking drugs boost heart disease risk when given in combination",
            "url": "https://www.health.harvard.edu/blog/testosterone-blocking-drugs-boost-heart-disease-risk-when-given-in-combination-202407263061",
            "content_html": "Androgen deprivation therapy can slow or control prostate cancer, and adding a second class of drugs improves survival when the disease is in advanced stages. But all drugs that block testosterone have challenging side effects, and a review of studies showed that cardiovascular risks worsen when these drugs are given together.",
            "summary": "Androgen deprivation therapy can slow or control prostate cancer, and adding a second class of drugs improves survival when the disease is in advanced stages. But all drugs that block testosterone have challenging side effects, and a review of studies showed that cardiovascular risks worsen when these drugs are given together.",
            "date_published": "2024-07-26T06:30:00-04:00",
            "date_modified": "2024-07-26T06:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/15477/conversions/59f61b05-2e23-463a-a0f7-b8aef6addd73-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medications and treatments" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/prostate-cancer-brachytherapy-linked-to-long-term-risk-of-secondary-malignancies-202406033046",
            "title": "Prostate cancer: Brachytherapy linked to long-term risk of secondary malignancies",
            "url": "https://www.health.harvard.edu/blog/prostate-cancer-brachytherapy-linked-to-long-term-risk-of-secondary-malignancies-202406033046",
            "content_html": "When cancer patients are treated with radiation, it's possible that the therapy itself may cause new tumors to form in the body later. Canadian researchers published findings in 2014 finding no difference between groups of men treated with cancer or with surgery - but following up another decade later, there was a clear increase in risk.",
            "summary": "When cancer patients are treated with radiation, it's possible that the therapy itself may cause new tumors to form in the body later. Canadian researchers published findings in 2014 finding no difference between groups of men treated with cancer or with surgery - but following up another decade later, there was a clear increase in risk.",
            "date_published": "2024-06-03T10:30:00-04:00",
            "date_modified": "2024-06-03T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/15280/conversions/b4859127-4f91-4bcc-a44b-93501bd52ed4-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medications and treatments" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/new-urine-test-may-help-some-men-with-elevated-psa-avoid-biopsy-202405063038",
            "title": "New urine test may help some men with elevated PSA avoid biopsy",
            "url": "https://www.health.harvard.edu/blog/new-urine-test-may-help-some-men-with-elevated-psa-avoid-biopsy-202405063038",
            "content_html": "When a PSA test produces an abnormal result, the next step is usually a prostate biopsy, but these have drawbacks. Researchers are exploring strategies to avoid unnecessary biopsies, and a test that screens for prostate cancer in urine samples has shown promising results in testing.",
            "summary": "When a PSA test produces an abnormal result, the next step is usually a prostate biopsy, but these have drawbacks. Researchers are exploring strategies to avoid unnecessary biopsies, and a test that screens for prostate cancer in urine samples has shown promising results in testing.",
            "date_published": "2024-05-06T10:30:00-04:00",
            "date_modified": "2024-05-06T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/15187/conversions/b61e9b15-b891-465f-8dbb-9aad58b1a830-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medical Tests & Procedures" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/what-complications-can-occur-after-prostate-cancer-surgery-202403133023",
            "title": "What complications can occur after prostate cancer surgery?",
            "url": "https://www.health.harvard.edu/blog/what-complications-can-occur-after-prostate-cancer-surgery-202403133023",
            "content_html": "Minimally invasive surgery to remove the prostate gland is generally very well tolerated, but there can be complications, as in the case of Defense Secretary Lloyd Austin earlier this year. A Harvard-affiliated urologist answers questions about the possibility of such complications.",
            "summary": "Minimally invasive surgery to remove the prostate gland is generally very well tolerated, but there can be complications, as in the case of Defense Secretary Lloyd Austin earlier this year. A Harvard-affiliated urologist answers questions about the possibility of such complications.",
            "date_published": "2024-03-13T10:30:00-04:00",
            "date_modified": "2024-03-13T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/15007/conversions/d94548f5-90dc-4d45-aebf-f231288c69ec-thumb.jpg",

            "tags": [ "Men's Health","Men's Health","Prostate Cancer","Surgical treatments and procedures" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/new-research-shows-little-risk-of-infection-from-prostate-biopsies-202402123013",
            "title": "New research shows little risk of infection from prostate biopsies",
            "url": "https://www.health.harvard.edu/blog/new-research-shows-little-risk-of-infection-from-prostate-biopsies-202402123013",
            "content_html": "Infections after a prostate biopsy are rare, but they do occur. There are two ways to perform such a biopsy, with the one at higher risk of infection more common in the US. Researchers conducted a trial designed to compare the safety of the two methods.",
            "summary": "Infections after a prostate biopsy are rare, but they do occur. There are two ways to perform such a biopsy, with the one at higher risk of infection more common in the US. Researchers conducted a trial designed to compare the safety of the two methods.",
            "date_published": "2024-02-12T10:30:00-05:00",
            "date_modified": "2024-02-12T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/14818/conversions/8bdf5afc-2fe3-4e6e-9ec6-f22b3d8b48dc-thumb.jpg",

            "tags": [ "Men's Health","Men's Health","Prostate Cancer","Medical Tests & Procedures" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/could-men-with-advanced-prostate-cancer-avoid-chemotherapy-202401083005",
            "title": "Could men with advanced prostate cancer avoid chemotherapy?",
            "url": "https://www.health.harvard.edu/blog/could-men-with-advanced-prostate-cancer-avoid-chemotherapy-202401083005",
            "content_html": "Men with advanced prostate cancer are typically treated with hormonal treatments followed by chemotherapy, but a recent study evaluated the potential of a treatment that uses radioactive particles injected into the body.",
            "summary": "Men with advanced prostate cancer are typically treated with hormonal treatments followed by chemotherapy, but a recent study evaluated the potential of a treatment that uses radioactive particles injected into the body.",
            "date_published": "2024-01-08T10:30:00-05:00",
            "date_modified": "2024-01-08T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/14691/conversions/e757d421-3c46-42fe-a230-8054f665823e-thumb.jpg",

            "tags": [ "Men's Health","Men's Health","Prostate Cancer","Medications and treatments" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/after-prostate-cancer-treatment-a-new-standard-of-care-for-rising-psa-202312203001",
            "title": "After prostate cancer treatment, a new standard of care for rising PSA",
            "url": "https://www.health.harvard.edu/blog/after-prostate-cancer-treatment-a-new-standard-of-care-for-rising-psa-202312203001",
            "content_html": "When prostate cancer recurs after initial treatment, doctors typically treat it with hormonal therapies. But results from a large clinical trial show that a different medication (or combination of two medications) is a better approach.",
            "summary": "When prostate cancer recurs after initial treatment, doctors typically treat it with hormonal therapies. But results from a large clinical trial show that a different medication (or combination of two medications) is a better approach.",
            "date_published": "2023-12-20T10:30:00-05:00",
            "date_modified": "2023-12-20T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/14611/conversions/caa17721-457e-4a5a-9616-3a4533864bfb-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Medications and treatments","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/fda-approves-new-surgical-treatment-for-enlarged-prostates-202310252985",
            "title": "FDA approves new surgical treatment for enlarged prostates",
            "url": "https://www.health.harvard.edu/blog/fda-approves-new-surgical-treatment-for-enlarged-prostates-202310252985",
            "content_html": "A transurethral resection of the prostate is considered the gold-standard treatment for benign prostatic hyperplasia. But newer, less invasive procedures offer faster recovery times and fewer risks of complications. Earlier this year another new procedure won the FDA's approval.",
            "summary": "A transurethral resection of the prostate is considered the gold-standard treatment for benign prostatic hyperplasia. But newer, less invasive procedures offer faster recovery times and fewer risks of complications. Earlier this year another new procedure won the FDA's approval.",
            "date_published": "2023-10-25T10:30:00-04:00",
            "date_modified": "2023-10-25T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/14469/conversions/fff19ecd-40d3-4487-ba44-1b3b96df7aaf-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Surgical treatments and procedures","Medical Tests & Procedures" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/prostate-cancer-a-new-type-of-radiation-treatment-limits-risk-of-side-effects-202309062969",
            "title": "Prostate cancer: A new type of radiation treatment limits risk of side effects",
            "url": "https://www.health.harvard.edu/blog/prostate-cancer-a-new-type-of-radiation-treatment-limits-risk-of-side-effects-202309062969",
            "content_html": "A new technique for prostate cancer treatment can limit side effects from radiation therapy. It relies on specialized types of medical imaging scans that allow doctors to visualize the cancer during treatment.",
            "summary": "A new technique for prostate cancer treatment can limit side effects from radiation therapy. It relies on specialized types of medical imaging scans that allow doctors to visualize the cancer during treatment.",
            "date_published": "2023-09-06T10:30:00-04:00",
            "date_modified": "2023-09-06T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/14256/conversions/de36fd85-9a94-4e65-8185-01a2bf4797af-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/prostate-cancer-an-emerging-surgical-alternative-shows-promise-in-older-men-202308092963",
            "title": "Prostate cancer: An emerging surgical alternative shows promise in older men",
            "url": "https://www.health.harvard.edu/blog/prostate-cancer-an-emerging-surgical-alternative-shows-promise-in-older-men-202308092963",
            "content_html": "In some men with localized prostate cancer, focal therapy is an alternative to radical prostatectomy. This procedure removes only the cancerous part of the gland, and growing evidence shows it can be an effective strategy.",
            "summary": "In some men with localized prostate cancer, focal therapy is an alternative to radical prostatectomy. This procedure removes only the cancerous part of the gland, and growing evidence shows it can be an effective strategy.",
            "date_published": "2023-08-09T00:00:00-04:00",
            "date_modified": "2023-08-09T00:00:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/14164/conversions/71109035-18a9-4837-9610-4d50896e3f01-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/fda-approves-new-treatment-for-advanced-prostate-cancer-202307122952",
            "title": "FDA approves new treatment for advanced prostate cancer",
            "url": "https://www.health.harvard.edu/blog/fda-approves-new-treatment-for-advanced-prostate-cancer-202307122952",
            "content_html": "Approval by the FDA of a new drug combination for treatment of advanced prostate cancer fills a need and offers new hope to men whose cancer has progressed and who have already tried other therapies.",
            "summary": "Approval by the FDA of a new drug combination for treatment of advanced prostate cancer fills a need and offers new hope to men whose cancer has progressed and who have already tried other therapies.",
            "date_published": "2023-07-12T10:30:00-04:00",
            "date_modified": "2023-07-12T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/14055/conversions/f9ca7018-05bb-4425-8f65-259c1bef4614-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Medications and treatments","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/young-men-with-prostate-cancer-socioeconomic-factors-affect-lifespan-202306122946",
            "title": "Young men with prostate cancer: Socioeconomic factors affect lifespan",
            "url": "https://www.health.harvard.edu/blog/young-men-with-prostate-cancer-socioeconomic-factors-affect-lifespan-202306122946",
            "content_html": "Prostate cancer is generally viewed as a disease of older men, yet about 10% of new diagnoses occur in men age 55 or younger. Biological differences partially explain the discrepancy, but socioeconomic factors also play an important role.",
            "summary": "Prostate cancer is generally viewed as a disease of older men, yet about 10% of new diagnoses occur in men age 55 or younger. Biological differences partially explain the discrepancy, but socioeconomic factors also play an important role.",
            "date_published": "2023-06-12T10:30:00-04:00",
            "date_modified": "2023-06-12T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/13969/conversions/575c5f12-a979-43ab-a883-c29c2b1cc9cd-thumb.jpg",

            "tags": [ "Healthcare Disparities","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/prostate-cancer-how-does-waiting-on-treatment-affect-survival-202304282929",
            "title": "How does waiting on prostate cancer treatment affect survival?",
            "url": "https://www.health.harvard.edu/blog/prostate-cancer-how-does-waiting-on-treatment-affect-survival-202304282929",
            "content_html": "Men who are diagnosed with certain types of prostate cancer often choose active surveillance, which allows them to delay the need for aggressive treatment. The results of a long-term study affirm that this approach is a valid option for managing the disease.
       
       
       ",
            "summary": "Men who are diagnosed with certain types of prostate cancer often choose active surveillance, which allows them to delay the need for aggressive treatment. The results of a long-term study affirm that this approach is a valid option for managing the disease.
       
       
       ",
            "date_published": "2023-04-28T06:30:00-04:00",
            "date_modified": "2023-04-28T06:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/13849/conversions/d7a57e47-960a-4173-bee2-fa5dcc27af41-thumb.jpg",

            "tags": [ "Men's Health","Men's Health","Prostate Cancer" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/prostate-cancer-in-transgender-women-202303242905",
            "title": "Prostate cancer in transgender women",
            "url": "https://www.health.harvard.edu/blog/prostate-cancer-in-transgender-women-202303242905",
            "content_html": "The increasing size and visibility of the transgender population has implications for public health. Hormone treatment given to transgender women lowers the overall risk of prostate cancer, but the risk of a trans woman developing the disease is not zero.",
            "summary": "The increasing size and visibility of the transgender population has implications for public health. Hormone treatment given to transgender women lowers the overall risk of prostate cancer, but the risk of a trans woman developing the disease is not zero.",
            "date_published": "2023-03-24T06:30:00-04:00",
            "date_modified": "2023-03-24T06:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/13714/conversions/59cf5aba-23d4-44df-af42-745568547301-thumb.jpg",

            "tags": [ "Cancer","LGBTQ+ health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/prostate-cancer-how-often-should-men-on-active-surveillance-be-evaluated-202302152890",
            "title": "Prostate cancer: How often should men on active surveillance be evaluated?",
            "url": "https://www.health.harvard.edu/blog/prostate-cancer-how-often-should-men-on-active-surveillance-be-evaluated-202302152890",
            "content_html": "Doctors used to recommend treating all men with prostate cancer; now they are likely to advise active surveillance for lower-risk cancers. But some men require closer monitoring — so how do they determine which ones?",
            "summary": "Doctors used to recommend treating all men with prostate cancer; now they are likely to advise active surveillance for lower-risk cancers. But some men require closer monitoring — so how do they determine which ones?",
            "date_published": "2023-02-15T10:30:00-05:00",
            "date_modified": "2023-02-15T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/13559/conversions/215e2279-9f76-4446-8d33-fa59dba9297d-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/what-are-the-chances-that-prostate-cancer-will-return-after-surgery-202301122874",
            "title": "What are the chances that prostate cancer will return after surgery?",
            "url": "https://www.health.harvard.edu/blog/what-are-the-chances-that-prostate-cancer-will-return-after-surgery-202301122874",
            "content_html": "In some men who have prostate cancer surgery the cancer never returns, while in others it does. A new type of imaging technology indicates the presence of prostate tumors, and researchers wanted to know if this could be used to predict cancer recurrence after treatment.",
            "summary": "In some men who have prostate cancer surgery the cancer never returns, while in others it does. A new type of imaging technology indicates the presence of prostate tumors, and researchers wanted to know if this could be used to predict cancer recurrence after treatment.",
            "date_published": "2023-01-12T10:30:00-05:00",
            "date_modified": "2023-01-12T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/13414/conversions/b19b890e-7ece-4e44-87be-f054e6fedec8-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/can-plant-based-diets-lower-your-risk-of-prostate-cancer-202212162867",
            "title": "Can plant-based diets lower your risk of prostate cancer?",
            "url": "https://www.health.harvard.edu/blog/can-plant-based-diets-lower-your-risk-of-prostate-cancer-202212162867",
            "content_html": "This year, results from a review of literature on plant-based diets and prostate cancer risk concluded that apart from having advantages for cardiovascular health, quality of life, and environmental benefits, plant-based diets have the potential to improve prostate cancer outcomes.",
            "summary": "This year, results from a review of literature on plant-based diets and prostate cancer risk concluded that apart from having advantages for cardiovascular health, quality of life, and environmental benefits, plant-based diets have the potential to improve prostate cancer outcomes.",
            "date_published": "2022-12-16T06:30:00-05:00",
            "date_modified": "2022-12-16T06:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/13341/conversions/0b271035-7647-481f-b690-5fca5d6b346f-thumb.jpg",

            "tags": [ "Men's Health","Healthy Eating","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/prostate-cancer-how-long-should-hormonal-therapy-last-202212052860",
            "title": "Prostate cancer: How long should hormonal therapy last?",
            "url": "https://www.health.harvard.edu/blog/prostate-cancer-how-long-should-hormonal-therapy-last-202212052860",
            "content_html": "Hormonal therapy is a cornerstone of prostate cancer treatment, but it has burdensome side effects. Doctors and patients alike are highly motivated to use this therapy only for as long as necessary. But how long is long enough? A recent study provides needed clarity.",
            "summary": "Hormonal therapy is a cornerstone of prostate cancer treatment, but it has burdensome side effects. Doctors and patients alike are highly motivated to use this therapy only for as long as necessary. But how long is long enough? A recent study provides needed clarity.",
            "date_published": "2022-12-05T10:30:00-05:00",
            "date_modified": "2022-12-05T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/13302/conversions/35ca4877-a4a2-4671-be14-9577af61e069-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/prostate-cancer-zapping-metastatic-tumors-with-radiation-improves-survival-202211072843",
            "title": "Prostate cancer: Zapping metastatic tumors with radiation improves survival",
            "url": "https://www.health.harvard.edu/blog/prostate-cancer-zapping-metastatic-tumors-with-radiation-improves-survival-202211072843",
            "content_html": "When prostate cancer spreads beyond the gland, it has been treated with hormone therapy, but there are challenging side effects. A new study shows that a different treatment option involving radiation can allow some men to delay or avoid hormone therapy.",
            "summary": "When prostate cancer spreads beyond the gland, it has been treated with hormone therapy, but there are challenging side effects. A new study shows that a different treatment option involving radiation can allow some men to delay or avoid hormone therapy.",
            "date_published": "2022-11-07T10:30:00-05:00",
            "date_modified": "2022-11-07T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/13217/conversions/b19b890e-7ece-4e44-87be-f054e6fedec8-thumb.jpg",

            "tags": [ "Men's Health","Medical Research","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/prostate-cancer-can-imaging-substitute-for-repeat-biopsies-during-active-surveillance-202210072825",
            "title": "Prostate cancer: Can imaging substitute for repeat biopsies during active surveillance?",
            "url": "https://www.health.harvard.edu/blog/prostate-cancer-can-imaging-substitute-for-repeat-biopsies-during-active-surveillance-202210072825",
            "content_html": "Men with lower-risk prostate cancer often opt for active surveillance, which involves regular testing and biopsies to check for possible tumor growth. A newer type of imaging may reduce the frequency of repeat biopsies for some men, but there are concerns about its limitations.",
            "summary": "Men with lower-risk prostate cancer often opt for active surveillance, which involves regular testing and biopsies to check for possible tumor growth. A newer type of imaging may reduce the frequency of repeat biopsies for some men, but there are concerns about its limitations.",
            "date_published": "2022-10-07T06:30:00-04:00",
            "date_modified": "2022-10-07T06:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/13135/conversions/515fa8b3-0e1a-4d45-8e39-3a085bfdc1b3-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/radiation-therapy-elevates-risks-for-future-cancers-202209092814",
            "title": "Prostate cancer: Radiation therapy elevates risk for future cancers",
            "url": "https://www.health.harvard.edu/blog/radiation-therapy-elevates-risks-for-future-cancers-202209092814",
            "content_html": "A standard treatment for localized prostate cancer is radiation, but there is a risk that it can lead to secondary cancers forming in the body later. Now, a large study of men treated with current radiation delivery methods clarifies that the amount of risk is low, but real.",
            "summary": "A standard treatment for localized prostate cancer is radiation, but there is a risk that it can lead to secondary cancers forming in the body later. Now, a large study of men treated with current radiation delivery methods clarifies that the amount of risk is low, but real.",
            "date_published": "2022-09-09T06:30:00-04:00",
            "date_modified": "2022-09-09T06:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/13055/conversions/c0282a05-12fa-49af-bd1a-6cdd4ceaeac0-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/promising-therapy-if-psa-rises-after-prostate-cancer-surgery-202208012792",
            "title": "Promising therapy if PSA rises after prostate cancer surgery",
            "url": "https://www.health.harvard.edu/blog/promising-therapy-if-psa-rises-after-prostate-cancer-surgery-202208012792",
            "content_html": "After a man has had a radical prostatectomy, sometimes the level of the antigen PSA rises again later, meaning cancer may have returned. A study found that the normal therapy given when this happens is more effective when combined with other forms of treatment.",
            "summary": "After a man has had a radical prostatectomy, sometimes the level of the antigen PSA rises again later, meaning cancer may have returned. A study found that the normal therapy given when this happens is more effective when combined with other forms of treatment.",
            "date_published": "2022-08-01T10:30:00-04:00",
            "date_modified": "2022-08-01T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/12959/conversions/1d16a423-89bf-4768-8891-5b3ac0e82585-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Surgical treatments and procedures" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/an-emerging-treatment-option-for-men-on-active-surveillance-202206292770",
            "title": "An emerging treatment option for men on active surveillance",
            "url": "https://www.health.harvard.edu/blog/an-emerging-treatment-option-for-men-on-active-surveillance-202206292770",
            "content_html": "Active surveillance allows men with low- or intermediate-risk prostate cancer to avoid temporarily the side effects of invasive therapies, but men often feel anxious about their cancer. Emerging evidence suggests there may be a middle path between no treatment and aggressive therapies.",
            "summary": "Active surveillance allows men with low- or intermediate-risk prostate cancer to avoid temporarily the side effects of invasive therapies, but men often feel anxious about their cancer. Emerging evidence suggests there may be a middle path between no treatment and aggressive therapies.",
            "date_published": "2022-06-29T10:30:00-04:00",
            "date_modified": "2022-06-29T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/12859/conversions/42ab193e-3bab-45f6-85b3-7465cad89272-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Medications and treatments","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/some-men-whose-prostate-cancer-progresses-can-safely-delay-treatment-202205232749",
            "title": "Some men whose prostate cancer progresses can safely delay treatment",
            "url": "https://www.health.harvard.edu/blog/some-men-whose-prostate-cancer-progresses-can-safely-delay-treatment-202205232749",
            "content_html": "Prostate cancer can progress over long durations, and if a man's tumor has features that predict slow growth, he can opt for active surveillance instead of immediate treatment. But when the time for treatment comes, up to a third of men still decide against it. Now, a new study finds that for some of these men, treatment can be safely delayed.",
            "summary": "Prostate cancer can progress over long durations, and if a man's tumor has features that predict slow growth, he can opt for active surveillance instead of immediate treatment. But when the time for treatment comes, up to a third of men still decide against it. Now, a new study finds that for some of these men, treatment can be safely delayed.",
            "date_published": "2022-05-27T06:30:00-04:00",
            "date_modified": "2022-05-27T06:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/12760/conversions/785e0513-ac8a-4077-b8d5-19ca8a86429f-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/new-treatment-approved-for-late-stage-prostate-cancer-202204072722",
            "title": "New treatment approved for late-stage prostate cancer",
            "url": "https://www.health.harvard.edu/blog/new-treatment-approved-for-late-stage-prostate-cancer-202204072722",
            "content_html": "The FDA has approved a new medication therapy for advanced prostate cancer that is spreading in the body. The new treatment can seek out and destroy tumors that are still too small to be found via conventional medical imaging. Results of a clinical trial showed that this new drug was effective at delaying cancer progression.",
            "summary": "The FDA has approved a new medication therapy for advanced prostate cancer that is spreading in the body. The new treatment can seek out and destroy tumors that are still too small to be found via conventional medical imaging. Results of a clinical trial showed that this new drug was effective at delaying cancer progression.",
            "date_published": "2022-04-07T15:30:00-04:00",
            "date_modified": "2022-04-07T15:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/12548/conversions/df7957f6-88ac-4f97-8a2e-ed022cf8169e-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medications and treatments" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/comparing-traditional-and-robotic-assisted-surgery-for-prostate-cancer-202203252713",
            "title": "Comparing traditional and robotic-assisted surgery for prostate cancer",
            "url": "https://www.health.harvard.edu/blog/comparing-traditional-and-robotic-assisted-surgery-for-prostate-cancer-202203252713",
            "content_html": "Today, most surgeries to remove the prostate gland in men with prostate cancer are performed with robotic assistance, which ostensibly offers quality-of-life advantages. But how does this method compare with traditional open surgery? A recent study provides some clarity.",
            "summary": "Today, most surgeries to remove the prostate gland in men with prostate cancer are performed with robotic assistance, which ostensibly offers quality-of-life advantages. But how does this method compare with traditional open surgery? A recent study provides some clarity.",
            "date_published": "2022-03-25T06:30:00-04:00",
            "date_modified": "2022-03-25T06:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/12520/conversions/df7957f6-88ac-4f97-8a2e-ed022cf8169e-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Surgical treatments and procedures" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/treatment-with-abiraterone-significantly-improves-survival-in-advanced-prostate-cancer-202201282678",
            "title": "Treatment with abiraterone significantly improves survival in advanced prostate cancer",
            "url": "https://www.health.harvard.edu/blog/treatment-with-abiraterone-significantly-improves-survival-in-advanced-prostate-cancer-202201282678",
            "content_html": "Currently, the medication abiraterone is approved for treatment of men with prostate cancer that has spread beyond the prostate gland and nearby lymph nodes. But a study found that men who received the drug at earlier stages (before the cancer had spread) in combination with another type of treatment were more likely to live longer than those who received only the control treatment.",
            "summary": "Currently, the medication abiraterone is approved for treatment of men with prostate cancer that has spread beyond the prostate gland and nearby lymph nodes. But a study found that men who received the drug at earlier stages (before the cancer had spread) in combination with another type of treatment were more likely to live longer than those who received only the control treatment.",
            "date_published": "2022-01-28T16:30:00-05:00",
            "date_modified": "2022-01-28T16:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/12259/conversions/df7957f6-88ac-4f97-8a2e-ed022cf8169e-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medications and treatments" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/new-study-investigates-treatment-associated-regrets-in-prostate-cancer-202201062665",
            "title": "New study investigates treatment-associated regrets in prostate cancer",
            "url": "https://www.health.harvard.edu/blog/new-study-investigates-treatment-associated-regrets-in-prostate-cancer-202201062665",
            "content_html": "Men who are diagnosed with prostate cancer have to make difficult choices about medical therapy, and hope that they will not later regret their treatment decisions. But a study found that such regrets are common, mainly because of differences between their expectations and actual experience.",
            "summary": "Men who are diagnosed with prostate cancer have to make difficult choices about medical therapy, and hope that they will not later regret their treatment decisions. But a study found that such regrets are common, mainly because of differences between their expectations and actual experience.",
            "date_published": "2022-01-06T15:30:00-05:00",
            "date_modified": "2022-01-06T15:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/12108/conversions/df7957f6-88ac-4f97-8a2e-ed022cf8169e-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/acupuncture-relieves-prostatitis-symptoms-in-study-202112012652",
            "title": "Acupuncture relieves prostatitis symptoms in study",
            "url": "https://www.health.harvard.edu/blog/acupuncture-relieves-prostatitis-symptoms-in-study-202112012652",
            "content_html": "Prostatitis is a common inflammatory condition, but most cases have no obvious cause. Treatments are varied and include anti-inflammatory painkillers and alpha blockers, but a clinical trial showed that acupuncture has the potential to reduce symptoms of prostatitis without the side effects that drugs can cause.",
            "summary": "Prostatitis is a common inflammatory condition, but most cases have no obvious cause. Treatments are varied and include anti-inflammatory painkillers and alpha blockers, but a clinical trial showed that acupuncture has the potential to reduce symptoms of prostatitis without the side effects that drugs can cause.",
            "date_published": "2021-12-01T15:00:00-05:00",
            "date_modified": "2021-12-01T15:00:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/12011/conversions/df7957f6-88ac-4f97-8a2e-ed022cf8169e-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/recent-study-shows-more-complications-with-alternative-prostate-biopsy-method-202111182641",
            "title": "Recent study shows more complications with alternative prostate biopsy method",
            "url": "https://www.health.harvard.edu/blog/recent-study-shows-more-complications-with-alternative-prostate-biopsy-method-202111182641",
            "content_html": "In the United States, screening tests for prostate cancer are mostly done as biopsies through the rectum, but this procedure comes with a risk of infection. Technical advances are making it possible for doctors to perform a different kind of biopsy procedure in their offices, and a recent study compared the two types.",
            "summary": "In the United States, screening tests for prostate cancer are mostly done as biopsies through the rectum, but this procedure comes with a risk of infection. Technical advances are making it possible for doctors to perform a different kind of biopsy procedure in their offices, and a recent study compared the two types.",
            "date_published": "2021-11-18T10:30:00-05:00",
            "date_modified": "2021-11-18T10:30:00-05:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/11927/conversions/df7957f6-88ac-4f97-8a2e-ed022cf8169e-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/study-no-effect-on-cognitive-functioning-from-treatments-for-advanced-prostate-cancer-202110112616",
            "title": "Study: No effect on cognitive functioning from treatments for advanced prostate cancer",
            "url": "https://www.health.harvard.edu/blog/study-no-effect-on-cognitive-functioning-from-treatments-for-advanced-prostate-cancer-202110112616",
            "content_html": "Some people being treated for cancer experience problems with memory and thinking, but most of the evidence for these effects comes from women undergoing treatment for breast cancer. A recent study looked at whether men being treated for prostate cancer experienced similar effects.",
            "summary": "Some people being treated for cancer experience problems with memory and thinking, but most of the evidence for these effects comes from women undergoing treatment for breast cancer. A recent study looked at whether men being treated for prostate cancer experienced similar effects.",
            "date_published": "2021-10-11T10:30:00-04:00",
            "date_modified": "2021-10-11T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/11791/conversions/df7957f6-88ac-4f97-8a2e-ed022cf8169e-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/cardiovascular-safety-from-prostate-cancer-drugs-remains-uncertain-202109242603",
            "title": "Cardiovascular safety from prostate cancer drugs remains uncertain",
            "url": "https://www.health.harvard.edu/blog/cardiovascular-safety-from-prostate-cancer-drugs-remains-uncertain-202109242603",
            "content_html": "Worldwide, over one million men are diagnosed with prostate cancer every year, and half will be given androgen deprivation therapy at some point. Whether certain types of this therapy are safer for the heart than others is an important question that is being studied, but the results from the first such trial were inconclusive and disappointing.",
            "summary": "Worldwide, over one million men are diagnosed with prostate cancer every year, and half will be given androgen deprivation therapy at some point. Whether certain types of this therapy are safer for the heart than others is an important question that is being studied, but the results from the first such trial were inconclusive and disappointing.",
            "date_published": "2021-09-24T14:30:00-04:00",
            "date_modified": "2021-09-24T14:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/11753/conversions/df7957f6-88ac-4f97-8a2e-ed022cf8169e-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health","Medications and treatments" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/level-of-health-literacy-affects-treatment-choice-for-slow-growing-prostate-cancer-202108242579",
            "title": "Level of health literacy affects treatment choice for slow-growing prostate cancer",
            "url": "https://www.health.harvard.edu/blog/level-of-health-literacy-affects-treatment-choice-for-slow-growing-prostate-cancer-202108242579",
            "content_html": "A genetic test that provides an assessment of how aggressive a man's prostate cancer is and how likely it is to spread within his body. A new study has investigated for the first time how results of this test are impacting treatment decisions — with surprising results.",
            "summary": "A genetic test that provides an assessment of how aggressive a man's prostate cancer is and how likely it is to spread within his body. A new study has investigated for the first time how results of this test are impacting treatment decisions — with surprising results.",
            "date_published": "2021-08-24T10:30:00-04:00",
            "date_modified": "2021-08-24T10:30:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/11575/conversions/df7957f6-88ac-4f97-8a2e-ed022cf8169e-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Men's Health" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/a-new-treatment-for-advanced-prostate-cancer-improves-survival-in-phase-3-clinical-trial-202107122543",
            "title": "A new treatment for advanced prostate cancer improves survival in phase 3 clinical trial",
            "url": "https://www.health.harvard.edu/blog/a-new-treatment-for-advanced-prostate-cancer-improves-survival-in-phase-3-clinical-trial-202107122543",
            "content_html": "Radiation therapy is getting more precise, making it easier to kill tumors while sparing their surrounding tissues. Some newer therapies deliver radiation particles directly to the cancer cell itself. One of these new therapies is now generating promising data for men with the most aggressive prostate cancer.",
            "summary": "Radiation therapy is getting more precise, making it easier to kill tumors while sparing their surrounding tissues. Some newer therapies deliver radiation particles directly to the cancer cell itself. One of these new therapies is now generating promising data for men with the most aggressive prostate cancer.",
            "date_published": "2021-07-12T00:00:00-04:00",
            "date_modified": "2021-07-12T00:00:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/11206/conversions/df7957f6-88ac-4f97-8a2e-ed022cf8169e-thumb.jpg",

            "tags": [ "Men's Health","Medications and treatments","Prostate Cancer" ]
        },
        {
            "id": "https://www.health.harvard.edu/blog/large-review-study-finds-low-risk-of-erectile-dysfunction-after-prostate-biopsy-202106102489",
            "title": "Large review study finds low risk of erectile dysfunction after prostate biopsy",
            "url": "https://www.health.harvard.edu/blog/large-review-study-finds-low-risk-of-erectile-dysfunction-after-prostate-biopsy-202106102489",
            "content_html": "Prostate cancer biopsies have a low risk of side effects, but some men do experience sexual dysfunction after the procedure. But a large review of sdudies has found that these issues usually resolve within one to three months.",
            "summary": "Prostate cancer biopsies have a low risk of side effects, but some men do experience sexual dysfunction after the procedure. But a large review of sdudies has found that these issues usually resolve within one to three months.",
            "date_published": "2021-06-10T12:00:00-04:00",
            "date_modified": "2021-06-10T12:00:00-04:00",
                        "authors": [                { "name": "C.W. Schmidt" }            ],
                        "image": "https://domf5oio6qrcr.cloudfront.net/medialibrary/10909/conversions/df7957f6-88ac-4f97-8a2e-ed022cf8169e-thumb.jpg",

            "tags": [ "Men's Health","Prostate Cancer","Medical Tests & Procedures" ]
        }        
    ]
}